EyeYon Medical’s EndoArt Heads to U.S. Clinical Trial After FDA IDE Approval
A synthetic sliver that could upend corneal edema care in the U.S.—no donor required. EndoArt (EyeYon Medical; Ness Ziona, Israel)…
Day 3 Dispatch: AAO 2025 Keeps the Pace in Orlando
The temps are up, coffee is on near-IV levels of drip, and the American Academy of Ophthalmology Annual Meeting 2025…
latest posts